Clinical Trial Update: Dose Escalation/De-escalation Study of Pre-operative Stereotactic Radiosurgery for Brain Metastases(RAD 1002) [Phase 1]

View source ↗

Summary

Phase 1 dose escalation/de-escalation study evaluating pre-operative stereotactic radiosurgery for patients with brain metastases (RAD 1002) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Brain Metastases | Phase 1 | Status: COMPLETED